113 related articles for article (PubMed ID: 38266459)
21. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.
Liu F; He Y; Shu R; Wang S
Int J Clin Exp Pathol; 2015; 8(5):4972-80. PubMed ID: 26191190
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma.
Zhang X; Zhang X; Wang T; Wang L; Tan Z; Wei W; Yan B; Zhao J; Wu K; Yang A; Zhang R; Jia L
Cancer Lett; 2018 Jul; 426():98-108. PubMed ID: 29653269
[TBL] [Abstract][Full Text] [Related]
24. HOXA11-AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR-124 expression by binding to EZH2.
Zhang WL; Zhao YN; Shi ZZ; Gu GY; Cong D; Wei C; Bai YS
Hum Cell; 2019 Oct; 32(4):504-514. PubMed ID: 31493246
[TBL] [Abstract][Full Text] [Related]
25. Reciprocal negative feedback loop between EZH2 and miR-101-1 contributes to miR-101 deregulation in hepatocellular carcinoma.
Huang D; Wang X; Zhuang C; Shi W; Liu M; Tu Q; Zhang D; Hu L
Oncol Rep; 2016 Feb; 35(2):1083-90. PubMed ID: 26718325
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-638 induces apoptosis and autophagy in human liver cancer cells by targeting enhancer of zeste homolog 2 (EZH2).
Zhang H; Liang H; Wu S; Zhang Y; Yu Z
Environ Toxicol Pharmacol; 2021 Feb; 82():103559. PubMed ID: 33290872
[TBL] [Abstract][Full Text] [Related]
27. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA FOXP4-AS1 facilitates the biological functions of hepatocellular carcinoma cells via downregulating ZC3H12D by mediating H3K27me3 through recruitment of EZH2.
Ye J; Fu Y; Wang Z; Yu J
Cell Biol Toxicol; 2022 Dec; 38(6):1047-1062. PubMed ID: 34545456
[TBL] [Abstract][Full Text] [Related]
29. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM
Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893
[TBL] [Abstract][Full Text] [Related]
30. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by
Huang B; Huang M; Li Q
Technol Cancer Res Treat; 2019; 18():1533033819879905. PubMed ID: 31757187
[TBL] [Abstract][Full Text] [Related]
31. Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression.
Zhang Y; Tang B; Song J; Yu S; Li Y; Su H; He S
J Exp Clin Cancer Res; 2019 Feb; 38(1):92. PubMed ID: 30786928
[TBL] [Abstract][Full Text] [Related]
32. MiRNA-506 presents multiple tumor suppressor activities by targeting EZH2 in nasopharyngeal carcinoma.
Fan DC; Zhao YR; Qi H; Hou JX; Zhang TH
Auris Nasus Larynx; 2020 Aug; 47(4):632-642. PubMed ID: 31932074
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA LINC01535 promotes cervical cancer progression via targeting the miR-214/EZH2 feedback loop.
Song H; Liu Y; Jin X; Liu Y; Yang Y; Li L; Wang X; Li G
J Cell Mol Med; 2019 Sep; 23(9):6098-6111. PubMed ID: 31273925
[TBL] [Abstract][Full Text] [Related]
34. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.
Xia H; Ooi LL; Hui KM
PLoS One; 2012; 7(9):e44206. PubMed ID: 22962603
[TBL] [Abstract][Full Text] [Related]
35. LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2.
Guo Y; Bai M; Lin L; Huang J; An Y; Liang L; Liu Y; Huang W
Biomed Pharmacother; 2019 Oct; 118():109272. PubMed ID: 31376657
[TBL] [Abstract][Full Text] [Related]
36. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
37. Circular RNA TTBK2 promotes the development of human glioma cells via miR-520b/EZH2 axis.
Yuan DH; Zhao J; Shao GF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10886-10898. PubMed ID: 31858557
[TBL] [Abstract][Full Text] [Related]
38. CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma.
Li CP; Cai MY; Jiang LJ; Mai SJ; Chen JW; Wang FW; Liao YJ; Chen WH; Jin XH; Pei XQ; Guan XY; Zeng MS; Xie D
Carcinogenesis; 2016 Jun; 37(6):557-566. PubMed ID: 27207647
[TBL] [Abstract][Full Text] [Related]
39. miR-381 Reverses Multidrug Resistance by Negative Regulation of the
Pu B; Yu X; Cao Y; Li Y; Tang L; Xia J
DNA Cell Biol; 2021 Dec; 40(12):1584-1596. PubMed ID: 34931867
[TBL] [Abstract][Full Text] [Related]
40. High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma.
Chen Z; Lin X; Wan Z; Xiao M; Ding C; Wan P; Li Q; Zheng S
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]